🇺🇸 FDA
Pipeline program

KIMMTRAK 100 micrograms/0.5 mL concentrate for solution for infusion

GEM 2302

Phase 2 small_molecule active

Quick answer

KIMMTRAK 100 micrograms/0.5 mL concentrate for solution for infusion for Metastatic uveal melanoma with resectable liver metastasis and absence of extra-liver disease is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Metastatic uveal melanoma with resectable liver metastasis and absence of extra-liver disease
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials